rs77524127
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_021116.4(ADCY1):c.1450-5G>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.012 in 1,613,326 control chromosomes in the GnomAD database, including 169 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_021116.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADCY1 | NM_021116.4 | c.1450-5G>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000297323.12 | NP_066939.1 | |||
ADCY1 | NM_001281768.2 | c.775-5G>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001268697.1 | ||||
ADCY1 | XM_005249584.4 | c.1450-5G>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | XP_005249641.1 | ||||
ADCY1 | XM_005249585.3 | c.1450-5G>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | XP_005249642.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADCY1 | ENST00000297323.12 | c.1450-5G>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_021116.4 | ENSP00000297323 | P1 | |||
ADCY1 | ENST00000432715.5 | c.775-5G>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 2 | ENSP00000392721 | |||||
ADCY1 | ENST00000621543.1 | c.775-5G>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 5 | ENSP00000479770 | |||||
ADCY1 | ENST00000646653.1 | n.391-5G>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0115 AC: 1747AN: 152138Hom.: 16 Cov.: 32
GnomAD3 exomes AF: 0.0126 AC: 3152AN: 250766Hom.: 42 AF XY: 0.0125 AC XY: 1699AN XY: 135474
GnomAD4 exome AF: 0.0121 AC: 17612AN: 1461070Hom.: 153 Cov.: 31 AF XY: 0.0120 AC XY: 8738AN XY: 726768
GnomAD4 genome AF: 0.0115 AC: 1745AN: 152256Hom.: 16 Cov.: 32 AF XY: 0.0118 AC XY: 882AN XY: 74442
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 10, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 05, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | c.1450-5G>T in intron 7 of ADCY1: This variant is not expected to have clinical significance because it has been identified in 1.66% (1102/66292) of European ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs77524127). - |
ADCY1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at